Cite
HARVARD Citation
Abreu, M. et al. (n.d.). DOP83 Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension. Journal of Crohn's and colitis. pp. S113-S115. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Abreu, M. et al. (n.d.). DOP83 Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension. Journal of Crohn's and colitis. pp. S113-S115. [Online].